RecallRadar

FDA Drug recall D-0179-2024

Enoxaparin Sodium Injection, USP, 150MG/ML Single-Dose Syringes with Automatic Safety Device, For Subcutaneous Injection, Ten 1 mL Syringes…

On 2024-01-03 the FDA classified a Class II recall of Enoxaparin Sodium Injection, USP, 150MG/ML Single-Dose Syringes with Automatic Safety Device, For Subcutaneous Injection, Ten 1 mL Syringes… by Cardinal Healthcare, citing CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0179-2024
ClassificationClass II
Statusterminated
Initiated2022-01-26
Published2024-01-03
Last updated2026-09-13 11:52 UTC
CompanyCardinal Healthcare
DistributionUS

Product

Enoxaparin Sodium Injection, USP, 150MG/ML Single-Dose Syringes with Automatic Safety Device, For Subcutaneous Injection, Ten 1 mL Syringes per box, Rx Only, Sandoz Inc, Princeton, NJ 08540. NDC: 0781-3299-69

Reason

CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.

Identifiers

ndc0781-3238-01
ndc0781-3238-63
ndc0781-3246-02
ndc0781-3246-64
ndc0781-3256-03
ndc0781-3256-66
ndc0781-3262-04
ndc0781-3262-68
ndc0781-3268-05
ndc0781-3268-69
ndc0781-3298-04
ndc0781-3298-68
ndc0781-3299-05
ndc0781-3299-69
code_infoBatch SAH06821A

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0179-2024%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.